Advertisement

Topics

PowderMed Limited Company Profile

07:33 EST 15th December 2018 | BioPortfolio

PowderMed is an immunotherapeutic product company located in Oxford, UK. We have six lead programmes targeting influenza, chronic viral diseases and cancer. These products are all based on our proprietary DNA particle mediated epidermal delivery (PMED™) technology. This technology has been extensively validated as a delivery technology in human trials.PowderMed was founded in May 2004. Although a young company, PowderMed was launched with six mature clinical and preclinical programmes and a management team with many years experience in the pharmaceutical industry. Thus PowderMed combines the dynamism and entrepreneurship of a biotech startup with the professionalism and maturity of a long-established pharmaceutical company. In the first year of activity, PowderMed announced its first clinical results in the influenza programme and launched three further Phase I trials in its therapeutic vaccine programmes. PowderMed also has a subsidiary called PowderMed Vaccines Inc, a United States (U.S.) based commercial entity in Frederick, Maryland, alongside the important National Biodefense Analysis and Counterterrorist Countermeasures (NBACC) centre at Fort Detrick.

Location

PO Box 1415
Oxford
Oxfordshire
OX4 4ZZ
United Kingdom

Contact

Phone: 01865 501500
Fax: 01865 501501
Email: contact@powdermed.com


News Articles [33 Associated News Articles listed on BioPortfolio]

C4X Discovery Appoints CEO

Dr Clive Dix has been appointed chief executive of Manchester-headquartered drug researcher C4X Discovery. He joined the business as non-executive chairman in October 2014 and became executive chairma...

Quotient Limited Announces Details of Investor Day

JERSEY, Channel Islands, July 16, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced details of its investor day held at the NASDAQ he...

Quotient Limited to Host Investor Day on July 16, 2018

JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it will host an Investor Day on Monday, July ...

Quotient Limited to Participate in the Jefferies 2018 London Healthcare Conference

JERSEY, Channel Islands, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Quotient (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chief Financial Officer, Chris Lindop,...

Quotient Limited Announces Initial MosaiQ™ SDS Verification and Validation Data

JERSEY, Channel Islands, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today reported positive Verification and Validation...

Quotient Limited Announces Pricing of Underwritten Offering of Ordinary Shares

JERSEY, Channel Islands, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the pricing of its previously annou...

Quotient Limited Announces Proposed Underwritten Offering of Ordinary Shares

JERSEY, Channel Islands, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the Company intends to commence an ...

Quotient Limited Announces Completion of Senior Secured Notes Offering

JERSEY, Channel Islands, July 02, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), has completed the offering of up to $120.0 million ...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [86 Associated Companies listed on BioPortfolio]

PowderMed Limited

PowderMed is an immunotherapeutic product company located in Oxford, UK. We have six lead programmes targeting influenza, chronic viral diseases and cancer. These products are all based on our proprie...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

VASUDHA PHARMA CHEM LIMITED

VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...

More Information about "PowderMed Limited" on BioPortfolio

We have published hundreds of PowderMed Limited news stories on BioPortfolio along with dozens of PowderMed Limited Clinical Trials and PubMed Articles about PowderMed Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PowderMed Limited Companies in our database. You can also find out about relevant PowderMed Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...


Corporate Database Quicklinks



Searches Linking to this Company Record